Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-β1 expression, and increases Foxp3-expressing cells in localized scleroderma-Reference-Cited by-同舟云学术

Subcutaneous administration of polymerized type I collagen downregulates interleukin (IL)-17A, IL-22 and transforming growth factor-β1 expression, and increases Foxp3-expressing cells in localized scleroderma

Published:2012-06-25 Issue:6 Volume:37 Page:599-609
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Furuzawa-Carballeda J.,Ortíz-Ávalos M.,Lima G.,Jurado-Santa Cruz F.,Llorente L.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2230.2012.04385.x/fullpdf

Reference25 articles.

1. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis;Badea;Rheumatol,2009

2. Localized scleroderma is an autoimmune disorder;Takehara;Rheumatol,2005

3. Cytokine profiles in localized scleroderma and relationship to clinical features;Kurzinski;Cytokine,2011

4. Th1 and Th17 cytokine signatures in early pediatric localized scleroderma;Torok;Arthritis Rheum,2010

5. Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study;Rodríguez-Reyna;Rheumatol Int,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymerized type I collagen down-regulates STAT-1 phosphorylation through engagement to LAIR-1 in M1-macrophages avoiding long COVID;2023-07-01

2. IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice;Arthritis Research & Therapy;2022-12-24

3. The Immunogenetics of Morphea and Lichen Sclerosus;The Immunogenetics of Dermatologic Diseases;2022

4. Effect of polymerized type I collagen in hyperinflammation of adult outpatients with symptomatic COVID-19: a double blind, randomised, placebo-controlled clinical trial;2021-05-17

5. Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy;Cell & Bioscience;2021-01-06